Resultados da busca - Ren‐Chin Wu
- Mostrando 1 - 20 resultados de 34
- Ir para a próxima página
-
1
The emerging roles of ARID1A in tumor suppression por Ren‐Chin Wu, Tian‐Li Wang, Ie‐Ming Shih
Publicado em 2014Revisão -
2
-
3
-
4
-
5
-
6
-
7
-
8
Glucan Binding Protein C of Streptococcus mutans Mediates both Sucrose-Independent and Sucrose-Dependent Adherence por Joshua L. Mieher, Matt Larson, Norbert Schormann, Sangeetha Purushotham, Ren‐Chin Wu, Kanagalaghatta R. Rajashankar, Hui Wu, Champion Deivanayagam
Publicado em 2018Artigo -
9
-
10
-
11
Increased proliferation in atypical hyperplasia/endometrioid intraepithelial neoplasia of the endometrium with concurrent inactivation of ARID1A and PTEN tumour suppressors por A. Ayhan, Tsui‐Lien Mao, Yohan Suryo Rahmanto, Felix Zeppernick, Hiroshi Ogawa, Ren‐Chin Wu, Tian‐Li Wang, Ie‐Ming Shih
Publicado em 2015Artigo -
12
ARID1A loss correlates with mismatch repair deficiency and intact p53 expression in high-grade endometrial carcinomas por Ghassan Allo, Marcus Q. Bernardini, Ren‐Chin Wu, Ie‐Ming Shih, Steve E. Kalloger, Aaron Pollett, C. Blake Gilks, Blaise Clarke
Publicado em 2013Artigo -
13
HOXA5 determines cell fate transition and impedes tumor initiation and progression in breast cancer through regulation of E-cadherin and CD24 por Wei Wen Teo, Vanessa F. Merino, Soonweng Cho, Preethi Korangath, Xiaohui Liang, Ren‐Chin Wu, Neil M. Neumann, Andrew J. Ewald, S Sukumar
Publicado em 2016Artigo -
14
NAC1 attenuates BCL6 negative autoregulation and functions as a BCL6 coactivator of FOXQ1 transcription in cancer cells por Min Gao, Alice Laschuk Herlinger, Ren‐Chin Wu, Tian‐Li Wang, Ie‐Ming Shih, Beihua Kong, Letícia Batista Azevedo Rangel, Jinming Yang
Publicado em 2020Artigo -
15
-
16
Inactivating ARID1A Tumor Suppressor Enhances TERT Transcription and Maintains Telomere Length in Cancer Cells por Yohan Suryo Rahmanto, Jin-Gyoung Jung, Ren‐Chin Wu, Yusuke Kobayashi, Christopher M. Heaphy, Alan K. Meeker, Tian‐Li Wang, Ie‐Ming Shih
Publicado em 2016Artigo -
17
CCNE1 copy-number gain and overexpression identify ovarian clear cell carcinoma with a poor prognosis por A. Ayhan, Elisabetta Kuhn, Ren‐Chin Wu, Hiroshi Ogawa, Asli Bahadirli-Talbott, Tsui-Lien Mao, Haruhiko Sugimura, Ie‐Ming Shih, Tian‐Li Wang
Publicado em 2016Artigo -
18
Lipocalin 2 (LCN2) is a promising target for cholangiocarcinoma treatment and bile LCN2 level is a potential cholangiocarcinoma diagnostic marker por Kun‐Chun Chiang, Ta‐Sen Yeh, Ren‐Chin Wu, Jong‐Hwei S. Pang, Chi‐Tung Cheng, Shang‐Yu Wang, Horng‐Heng Juang, Chun‐Nan Yeh
Publicado em 2016Artigo -
19
Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy por Ren‐Chin Wu, A. Ayhan, Daichi Maeda, Kyu‐Rae Kim, Blaise Clarke, Patricia Shaw, M. Herman Chui, Barry P. Rosen, Ie‐Ming Shih, Tian‐Li Wang
Publicado em 2013Artigo -
20
Ferramentas de busca:
Assuntos relacionados
Biology
Genetics
Cancer research
Medicine
Cancer
Gene
Internal medicine
Ovarian cancer
Oncology
Pathology
Biochemistry
Mutation
Carcinoma
Cell biology
ARID1A
Immunology
Carcinogenesis
Clear cell carcinoma
Immunohistochemistry
Endometrial cancer
Immune system
Metastasis
Ovarian carcinoma
Serous fluid
Cell
Ectopic expression
Gene knockdown
Gene silencing
Molecular biology
Receptor